Kai Chen
Corporate Officer/Principal chez IOMAI CORPORATION
Profil
Kai Chen is Vice President of Business Development for Iomai Corp.
Prior to joining Iomai, he was Chief of the Cancer and Biological Modifiers Branch of the NIH's Office of Technology Transfer.
Previously, he worked at MedImmune, Inc. Dr. Chen received a PhD in Biophysics from the University of Illinois and an MBA in Technology Management and Marketing from University of California, Los Angeles.
Postes actifs de Kai Chen
| Sociétés | Poste | Début |
|---|---|---|
| IOMAI CORPORATION | Corporate Officer/Principal | - |
Anciens postes connus de Kai Chen
| Sociétés | Poste | Fin |
|---|---|---|
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | - |
Formation de Kai Chen
| University of Illinois | Doctorate Degree |
| University of California, Los Angeles | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Intercell USA, Inc.
 Intercell USA, Inc. BiotechnologyHealth Technology Intercell USA, Inc. discovers and develops vaccines and immune system stimulants. The vaccine patch enhances the efficacy of existing vaccines, enables new vaccines that are viable only through transcutaneous administration and expand the global vaccine market. The company was founded by Gregory M. Glenn and Dean P. Lewis in September 1997 and is headquartered in Gaithersburg, MD. | Health Technology |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
